Abstract
Recombinant tumour necrosis factor (TNF) promotes survival and induces proliferation in the tumour cells from two malignancies of B lymphocytes - hairy-cell leukaemia and B-chronic lymphocytic leukaemia. Culture with TNF also induces TNF mRNA and protein, so the cytokine may act as an autocrine tumour growth factor. These growth promoting effects are antagonised by alpha but not by gamma interferon.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 969-971 |
| Number of pages | 3 |
| Journal | The Lancet |
| Volume | 331 |
| Issue number | 8592 |
| DOIs | |
| State | Published - Apr 30 1988 |
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS